What to look for: A practice that specializes in obesity medicine, sees you weekly or monthly (not annually), and has a track record of managing long-term GLP-1 care
Typically, they are benign and cause no pain or symptoms, but they may be confused with melanoma
GLP-1 receptor agonists in heart failure GLP-1 receptor agonists have demonstrated favorable cardiovascular effects in patients with T2DM and obesity as meta-analyses suggest a reduction in hospitalization for incident or new-onset HF of approximately 18%, alongside reductions in major adverse cardiovascular events [6, 14, 15]
What time of day should I inject retatrutide
Patient adds 1 mL, swirls, then adds another 1 mL
The GH/IGF-1 system in critical illness